Skip to main content
OpenTrials
Completed

NCT Number: NCT04430322

Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study

France and especially the region "Grand Est" have been damaged by the COVID-19 pandemic. This pandemic resulted in a reorganization of the hospitalization sectors.

In order to better understand the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient data. This study would notably allow us to identify some prognostic factors.

The main objective of this study is to identify individual factors that are associated with a poor prognosis (with ICU admission or death).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID

Sex eligibility

All sexes

Study type

Observational

Primary location

CHR Metz Thionville

Metz, 57085, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient hospitalized in COVID Unit at the Regional Hospital Center Metz-Thionville during the COVID 19 pandemic
  • PCR positive or COVID confirmed with clinical evidence and CT scan

Exclusion criteria

  • Patients not willing to participate via using their medical files
  • Patient transferred after a brief stay in another hospital

Treatment and study plan

Primary outcomes

  1. ICU admission

    Time frame: Day 1

    Number of ICU admission during the hospitalization

Secondary outcomes

  1. Hospitalization

    Time frame: Day 1

    The duration of the hospitalization

  2. Length of stay at the ICU

    Time frame: Day 1

    The duration of stay at the ICU

  3. Death

    Time frame: Day 1

    The occurrence of death during the stay

  4. CT scan result

    Time frame: Day 1

    Evocative CT scan result

  5. C reactive protein

    Time frame: Day 1

    C reactive protein value

  6. Blood Count

    Time frame: Day 1

    Blood Count value

  7. Sodium

    Time frame: Day 1

    Sodium value

  8. Urea

    Time frame: Day 1

    Urea value

  9. Troponine

    Time frame: Day 1

    Troponine value via biological data

  10. Liver function

    Time frame: Day 1

    Transaminases value

  11. Coagulation test

    Time frame: Day 1

    Quick test result

  12. Creatinine

    Time frame: day 1

    creatinine value

  13. Clearance

    Time frame: day 1

    creatinine clearance value

  14. Potassium

    Time frame: day 1

    potassium value

  15. Calcium

    Time frame: day 1

    calcium value

  16. Gamma-glutamyl transpeptidase

    Time frame: day 1

    Gamma-glutamyl transpeptidase value

  17. Bilirubine

    Time frame: day 1

    Bilirubine value

  18. Alcaline phosphatase

    Time frame: Day 1

    Alcaline phosphatase value

  19. Prothrombine

    Time frame: Day 1

    Prothrombine value

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Régional Metz-Thionville

Other

Registry information

Official study title

Coronavirus Disease 2019 (Covid-19) at the Regional Hospital Center Metz-Thionville: a Descriptive Study

Acronym: COMETE-19

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jun 12, 2020
Registry last updated
Aug 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.